|
KMID : 1812020230290010058
|
|
Journal of Neurogastroenterology and Motility
2023 Volume.29 No. 1 p.58 ~ p.64
|
|
|
Effects of Tegoprazan Versus Esomeprazole on Nighttime Heartburn and Sleep Quality in Gastroesophageal Reflux Disease: A Multicenter Double-blind Randomized Controlled Trial
|
|
Kim Joon-Sung
Seo Seung-In
Kang Sun-Hyung
Lee Sang-Kil
Kim Ah-Rong
Park Hyun-Wook
Kim Bong-Tae
Song Geun-Seog
|
|
|
Abstract
|
|
|
Background/AimsPatients with gastroesophageal reflux disease (GERD) frequently experience nighttime heartburn and sleep disturbance. Tegoprazan is a new potassium-competitive acid blocker that can rapidly block acid secretion. This study aims to evaluate the efficacy of tegoprazan compared with esomeprazole in relieving nighttime heartburn and sleep disturbances.
MethodsPatients with erosive esophagitis, nighttime heartburn, and sleep disturbances were randomized to receive tegoprazan 50 mg or esomeprazole 40 mg for 2 weeks. The primary endpoint was time to first nighttime heartburn-free interval. The percentage of nighttime heartburn-free days was also compared between the 2 groups.
ResultsA total of 46 patients were enrolled in this study. Time to the first nighttime heartburn-free interval was shorter with tegoprazan than with esomeprazole but the difference was not statistically significant (1.5 days vs 3 days, P = 0.151). The percentage of nighttime heartburn-free days was higher in the tegoprazan group but the difference was insignificant (57.8% vs 43.1%, P = 0.107). Adverse events occurred in 2 patients. They were mild in severity.
ConclusionsTegoprazan may induce faster relief of nighttime heartburn symptoms and may improve sleep disorders associated with nighttime heartburn. Further large-scale studies are required to validate our findings.
|
|
|
KEYWORD
|
|
|
Gastroesophageal reflux, Heartburn, Potassium channel blockers, Proton pump inhibitors, Sleep wake disorders
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|